FIELD: chemistry.
SUBSTANCE: invention refers to compounds of the formula (I): , where R1 is C1-C8alkyl optionally substituted with one to three substitutes selected out of substitute group A; R2 is C1-C6alkyl or C1-C6alkoxyC1-C6alkyl; R3 is C1-C6alkyl or C1-C6alkoxy; or R2 and R3 together with adjoining carbon atoms form optionally substituted non-aromatic 5-10-member carbon ring; R4 is hydrogen; G is group represented by the formula: or the rest as provided in the invention claim; and to pharmaceutical composition, application of claimed compounds, and method of atopic dermatitis prevention or treatment.
EFFECT: novel compounds useful as atopic dermatitis treatment medication and antipruritic medicines.
24 cl, 75 ex, 290 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRIDIN DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS | 2004 |
|
RU2353617C2 |
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | 2014 |
|
RU2662832C2 |
MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS | 2014 |
|
RU2678830C2 |
DERIVATIVES OF CARBOXYLIC ACIDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FO SELECTIVE BINDING αβ-INTEGRIN IN MAMMAL | 2000 |
|
RU2263109C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
NOVEL PYRIDINONES AND PYRIDAZINONES | 2009 |
|
RU2505538C2 |
TREATMENT METHOD | 2012 |
|
RU2621148C2 |
NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619130C2 |
Authors
Dates
2010-06-20—Published
2005-10-28—Filed